Eicosapentaenoic Acid Cerebral Vasospasm Therapy Study (EVAS)
Eicosapentaenoic Acid Cerebral Vasospasm Therapy Study (EVAS): Effect of Eicosapentaenoic Acid on Cerebral Vasospasm Following Subarachnoid Hemorrhage
Sponsor: Iwate Medical University
A PHASE4 clinical study on Cerebral Vasospasm and Subarachnoid Hemorrhage, this trial is completed. The trial is conducted by Iwate Medical University and has accumulated 5 data snapshots since 2004. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE4
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE4
First recorded
Dec 2004
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Iwate Medical University
- Nakamura Memorial Hospital
- Ootemachi Hospital
- Tohoku University
- Yamaguchi University Hospital
For direct contact, visit the study record on ClinicalTrials.gov .